Integra LifeSciences Holdings Corporation (IART) Earnings History
Annual and quarterly earnings data from 1995 to 2025
Loading earnings history...
IART EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IART Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 51.7% | 4.2% | -31.6% |
| 2024 | 54.8% | 1.8% | -0.4% |
| 2023 | 57.4% | 7.2% | 4.4% |
| 2022 | 62.3% | 15.3% | 11.6% |
| 2021 | 61.2% | 12.8% | 11.0% |
Download Data
Export IART earnings history in CSV or JSON format
Free sign-in required to download data
Integra LifeSciences Holdings Corporation (IART) Earnings Overview
As of May 8, 2026, Integra LifeSciences Holdings Corporation (IART) reported trailing twelve-month net income of -$496M, reflecting -7361.2% year-over-year growth. The company earned $-6.44 per diluted share over the past four quarters, with a net profit margin of -31.6%.
Looking at the long-term picture, IART's historical earnings data spans multiple years. The company achieved its highest annual net income of $181M in fiscal 2022.
Integra LifeSciences Holdings Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HOLX ($544M net income, 13.8% margin), NVCR (-$173M net income, -20.8% margin), ATRC (-$5M net income, -2.1% margin), IART has room to improve margins relative to the peer group. Compare IART vs HOLX →
IART Earnings vs Peers
Earnings metrics vs comparable public companies
IART Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$516M | -7337.7% | $68M | $-6.73 | -31.6% | 4.2% |
| 2024 | -$7M | -110.3% | $28M | $-0.09 | -0.4% | 1.8% |
| 2023 | $68M | -62.5% | $112M | $0.84 | 4.4% | 7.2% |
| 2022 | $181M | +6.8% | $239M | $2.16 | 11.6% | 15.3% |
| 2021 | $169M | +26.3% | $197M | $1.98 | 11.0% | 12.8% |
| 2020 | $134M | +166.7% | $151M | $1.57 | 9.8% | 11.0% |
| 2019 | $50M | -17.4% | $94M | $0.58 | 3.3% | 6.2% |
| 2018 | $61M | -6.1% | $111M | $0.72 | 4.1% | 7.5% |
| 2017 | $65M | -13.2% | $45M | $0.82 | 5.4% | 3.8% |
| 2016 | $75M | +2218.9% | $115M | $0.94 | 7.5% | 11.6% |
See IART's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IART Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IART vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIART — Frequently Asked Questions
Quick answers to the most common questions about buying IART stock.
Is IART growing earnings?
IART EPS fell to $-6.44, with earnings declining -7361.2%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-496M.
What are IART's profit margins?
Integra LifeSciences Holdings Corporation net margin is -31.6%, with operating margin at +4.2%. Below-average margins reflect competitive or cost pressures.
How consistent are IART's earnings?
IART earnings data spans 1995-2025. The declining earnings trend is -7361.2% YoY. Historical data enables comparison across business cycles.